A carregar...
Thymidylate synthase predicts poor response to pemetrexed chemotherapy in patients with advanced breast cancer
Pemetrexed is a candidate chemotherapy regimen for anthracycline- and taxane-pretreated advanced breast cancer. However, to the best of our knowledge, no efficient treatment efficacy biomarkers have been identified. In the present study, the potential correlation between thymidylate synthase (TYMS)...
Na minha lista:
| Publicado no: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096094/ https://ncbi.nlm.nih.gov/pubmed/30127925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8973 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|